Additional Information
Market:ASX
Sector:General Mining
EPIC:UEQ
Latest Price: 0.04  (0.00%)
52-week High:0.18
52-week Low:0.04
Market Cap:9.25M
1 year chart
digital-look imported chart image
1 day chart
digital-look imported chart image
Uranium Equities

Uranium Equities (ASX: UEQ) has a portfolio of uranium focused exploration projects in Australia, with a focus on South Australia and the Northern Territory.

 

The company has two main areas of focus: The development of the PhosEnergy Process; and exploration
activities directed at a small core of high quality exploration assets which include the key Nabarlek Project.

Uranium Equities partners with Cameco Corp. in US$16.5 million deal to develop PhosEnergy Process

Monday, November 09, 2009
Uranium Equities partners with Cameco Corp. in US$16.5 million deal to develop PhosEnergy Process

South Australian-based company Uranium Equities (ASX: UEQ) has secured funding of up to US$16.5 million through uranium giant Cameco Corporation (NYSE: CCJ) for the ongoing development and commercialisation of the PhosEnergy Process.

Under the deal, Cameco will have the right to earn up to 70% of UEQ’s right to take a 90% stake in the technology in two tranches.

Saskatchewan-based Cameco is one of the world’s largest uranium producers and suppliers of conversion services.

The first tranche of US$2.5M will earn Cameco a 10.6% interest with subsequent investment tranches of two lots of US$5M and a final US$4M to see its interest increase incrementally.

Cameco has the option to cease sole funding at the conclusion of each tranche.

If Cameco funds the entire US$16.5M, the company will provide a funding facility for a minimum of 50% of UEQ’s portion of capital expenditure related to the construction of the first commercial plant developed by the joint entity under terms to be determined which would include repayment out of earnings.

A Joint Technical and Commercial Committee is to be established to guide the development which will utilise the significant in-house process engineering expertise of Cameco and UEQ in the field of uranium recovery from phosphate streams.

Shares in Uranium Equities last traded at 16.5c on the Australian Stock Exchange.

The PhosEnergy Process is an innovative patented process for the extraction of uranium as a by-product from phosphate in the production of phosphate based fertilisers.

The global annual production potential of uranium from the phosphate industry is about 20 Mlbs U3O8. This quantity of uranium is mined in phosphate ores but not recovered annually on a worldwide basis.

The major phosphate based fertiliser producers are located in Northern Africa, North America and Asia.

The PhosEnergy Process has been proven to pilot scale with results establishing a robust process capable of achieving high levels of uranium recovery at the lower end of the cost.

Operating cost estimates based on the pilot plant operation results indicate the PhosEnergy Process is capable of producing uranium at operating costs in the order of US$25-$30/lb with over 90% uranium recovery.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.